Cdh16‐Cre/Mfn2
flox/flox mice develops malignant lesions and exhibits EGFR signaling pathway activation. (A) Experimental scheme for generating the Mfn2
CKO mice. (B) Representative images of kidneys of Mfn2
CKO and control Mfn2
flox/flox mice taken at 40 weeks of age. (C) Representative H&E staining of kidney sections of 40‐week‐old control and Mfn2
CKO mice. (D) Representative H&E staining of kidney sections. (i) H&E staining of control mice display normal kidney morphology. (ii‐vi) H&E staining of kidney sections of Mfn2
CKO mice shows solid dysplasia (ii), clear cytoplasm (iii), a simple cyst lined by a single epithelial layer (iv), a cyst showing atypical epithelial cell proliferation (multi‐layered) (v) and a cyst showing extensive proliferation of epithelial cells into the cyst lumen (vi). (E) Representative IHC staining images of p‐EGFR, p‐AKT and p‐ERK in kidney sections of control and Mfn2
CKO mice (n = 3 per group). IHC scores are shown. (F) Western blotting analysis of indicated proteins in EGF‐treated primary renal tubular epithelial cells isolated from control and Mfn2
CKO mice. (G) Representative H&E staining of kidney sections from Ctrl, Vhl
CKO, Mfn2
CKO and VhlMfn2
CKO mice.
Abbreviations: Mfn2
CKO, Cdh16‐Cre/Mfn2
flox/flox mice; CKO, conditional knockout; Ctrl, control Mfn2
flox/flox mice; H&E, hematoxylin and eosin; EGF, epidermal growth factor; Vhl, Von Hippel‐Lindau Tumor Suppressor; Vhl
CKO, Cdh16‐CreVhl
flox/flox mouse; VhlMfn2
CKO, Cdh16‐Cre/Vhl
flox/flox
/Mfn2
flox/flox mice.